Torrent Pharmaceuticals Ltd
TORNTPHARMTorrent Pharmaceuticals Ltd
TORNTPHARM![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/midcap.png)
![](https://assets.tickertape.in/sector-icons/low_risk.png)
Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
57.63 | 13.92 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
43.04 | 6.19 | 0.55% |
Forecast & Ratings
Detailed Forecastfrom 28 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 6,912.50 | 6,038.99 | 6,248.67 | 7,729.85 | 8,060.61 | 8,061.48 | 8,704.60 | 9,665.29 | 10,874.13 | 10,874.00 | ||||||||||
Raw Materials | 1,725.04 | 1,931.39 | 2,035.67 | 2,136.25 | 2,300.05 | 2,425.66 | 2,368.15 | 2,569.00 | 2,841.22 | 7,360.00 | ||||||||||
Power & Fuel Cost | 92.59 | 107.98 | 118.77 | 132.46 | 128.19 | 122.94 | 144.19 | 155.28 | 145.20 | |||||||||||
Employee Cost | 842.35 | 993.41 | 1,135.25 | 1,403.79 | 1,429.04 | 1,439.62 | 1,526.45 | 1,677.69 | 1,984.40 | |||||||||||
Selling & Administrative Expenses | 847.92 | 964.14 | 1,084.65 | 1,299.49 | 1,317.15 | 1,155.10 | 1,278.57 | 1,502.70 | 1,674.65 | |||||||||||
Operating & Other expenses | 639.63 | 441.50 | 226.24 | 1,074.76 | 594.52 | 381.17 | 1,244.11 | 873.43 | 714.72 | |||||||||||
EBITDA | 2,764.97 | 1,600.57 | 1,648.09 | 1,683.10 | 2,291.66 | 2,536.99 | 2,143.13 | 2,887.19 | 3,513.94 | 3,514.00 | ||||||||||
Depreciation/Amortization | 237.55 | 306.92 | 408.60 | 617.69 | 654.38 | 657.79 | 662.16 | 706.59 | 808.27 | 808.00 | ||||||||||
PBIT | 2,527.42 | 1,293.65 | 1,239.49 | 1,065.41 | 1,637.28 | 1,879.20 | 1,480.97 | 2,180.60 | 2,705.67 | 2,706.00 | ||||||||||
Interest & Other Items | 183.98 | 205.56 | 308.48 | 503.75 | 450.71 | 352.94 | 255.06 | 333.44 | 353.56 | 354.00 | ||||||||||
PBT | 2,343.44 | 1,088.09 | 931.01 | 561.66 | 1,186.57 | 1,526.26 | 1,225.91 | 1,847.16 | 2,352.11 | 2,352.00 | ||||||||||
Taxes & Other Items | 610.20 | 154.54 | 252.90 | 125.38 | 161.85 | 274.38 | 448.73 | 601.93 | 695.73 | 696.00 | ||||||||||
Net Income | 1,733.24 | 933.55 | 678.11 | 436.28 | 1,024.72 | 1,251.88 | 777.18 | 1,245.23 | 1,656.38 | 1,656.00 | ||||||||||
EPS | 51.21 | 27.58 | 20.03 | 12.89 | 30.28 | 36.99 | 22.96 | 36.79 | 48.94 | 48.93 | ||||||||||
DPS | 17.50 | 7.00 | 7.00 | 8.50 | 16.00 | 17.50 | 24.00 | 22.00 | — | 30.00 | ||||||||||
Payout ratio | 0.34 | 0.25 | 0.35 | 0.66 | 0.53 | 0.47 | 1.05 | 0.60 | 0.00 | 0.61 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Torrent Pharmaceuticals Ltd | 57.61 | 13.92 | — |
Sun Pharmaceutical Industries Ltd | 38.18 | 6.16 | 0.89% |
Cipla Ltd | 29.17 | 5.07 | 0.87% |
Zydus Lifesciences Ltd | 28.02 | 5.49 | 0.28% |
Price Comparison
Compare TORNTPHARM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Kotak Emerging Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6524% | Percentage of the fund’s portfolio invested in the stock 1.38% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/81 (-1) |
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3045% | Percentage of the fund’s portfolio invested in the stock 1.21% | Change in the portfolio weight of the stock over the last 3 months -0.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/68 (-4) |
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1705% | Percentage of the fund’s portfolio invested in the stock 2.27% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/35 (+1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJun 21, 2024
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2024
Cash Dividend
Ex DateEx DateFeb 12, 2024
Dividend/Share
₹22.00
Ex DateEx Date
Feb 12, 2024
Cash Dividend
Ex DateEx DateJun 23, 2023
Dividend/Share
₹8.00
Ex DateEx Date
Jun 23, 2023
Cash Dividend
Ex DateEx DateFeb 3, 2023
Dividend/Share
₹14.00
Ex DateEx Date
Feb 3, 2023
Cash Dividend
Ex DateEx DateJun 3, 2022
Dividend/Share
₹15.00
Ex DateEx Date
Jun 3, 2022
News & Opinions
Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit
2 weeks ago•Business Standard
Torrent Pharma’s Indrad facility gets Form 483 with 5 observations from US FDA
2 weeks ago•Business Standard
Buzzing stocks, June 13: BLS In’t, DrReddy’s, Sobha, Torrent Pharma, Gensol
2 weeks ago•Business Standard
Stocks To Watch: RVNL, BHEL, Torrent Pharmaceuticals, KPI Green Energy
3 weeks ago•Bloomberg Quint
Stocks To Watch: LIC, Torrent Pharma, NTPC, United Spirits
1 month ago•Bloomberg Quint
Q4 Results Today: Hindalco, NTPC, Torrent Pharma Among 250+ Companies To Report Earnings
1 month ago•Bloomberg Quint
New buy signal generated in these 4 F&0 scrips as per RMI scanner
3 months ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.06%, vs industry avg of 9%
Decreasing Market Share
Over the last 5 years, market share decreased from 3.49% to 3.01%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 30.58%, vs industry avg of 15.09%